Please login to the form below

Not currently logged in
Email:
Password:

Biomarker

This page shows the latest Biomarker news and features for those working in and with pharma, biotech and healthcare.

Novartis’ heart failure drug Entresto proves superior to enalapril

Novartis’ heart failure drug Entresto proves superior to enalapril

In that study Entresto delivered significantly greater (29%) and more rapid reductions in time-averaged N-terminal pro-B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity ... PIONEER-HF further confirmed the safety

Latest news

More from news
Approximately 5 fully matching, plus 268 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    The company has identified the novel biomarker of tumour mutation burden as a key plank of its growth strategy for the immunotherapy.

  • Industry appointments Industry appointments

    Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma

  • Annalisa Jenkins joins biomarker firm PlaqueTec as CEO Annalisa Jenkins joins biomarker firm PlaqueTec as CEO

    Annalisa Jenkins joins biomarker firm PlaqueTec as CEO. She arrives from US-based Dimension Therapeutics, where she was CEO. ... UK-based PlaqueTec has appointed Annalise Jenkins as its chief executive officer, a role that will see her lead the 2018

  • Paul Stockdale joins Oxford BioDynamics as CFO Paul Stockdale joins Oxford BioDynamics as CFO

    A spin-out from Oxford University, Oxford BioDynamics focuses on the discovery and development of epigenetic biomarkers based on regulatory genome architecture.

  • Stephen Eck joins Aravive Biologics Stephen Eck joins Aravive Biologics

    Ray Tabibiazar, founding president and CEO of Aravive, said: “Stephen has an impressive track-record of oncology drug and biomarker development at prominent pharmaceutical companies, as well as a close relationship

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics